Merck & Co (MRK)
$126.45
0.60 (0.48%)
MRK Stock Quote Delayed 30 Minutes
Profit From the Retiree Rocket
There are lots of ways to play the baby boomer market, but health care is among the best. Consider this options trade on Medtronic.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
320.09B
PE Ratio
140.50
EPS
0.9
Volume (Avg. Vol.)
6.79M
Day's Range
$124.91 - $126.60
52-Week Range
$99.14 - $134.63
Dividend & Yield
$2.92 (2.31%)
MRK Stock Predictions, Articles, and Merck & Co News
6 Stocks to Sell in September
The near-term trend is down, and these company names are dangerously overpriced. From Intel to Merck, see this month's list of stocks to sell.
11 American Corporations Set for Global Shopping Sprees
A legal tax dodge for U.S. companies buying offshore assets should look attractive to these 11 big multinational stocks with huge foreign stockpiles.
Gilead Poised to Go From Good to Great?
Gilead faces a pivotal FDA decision on its HIV "quad" pill Monday. Even if it's not much better than what's available, approval would be good news for investors.
The 10 Best Buffett Dividend Stocks
Despite paring back on several dividend stocks last quarter, Berkshire hasn't given up on income altogether. Here are its top dividend payers.
Eli Lilly Might Have an Alzheimer’s Cure
Eli Lilly's stock is set to soar Friday morning after a trial for its Alzheimer's drug solanezumab showed promising results for early-stage patients.
Forget ‘Earnings’ — Declining Revenue and Dividends the Real Story in Q3
The biggest concern for investors should be the individual companies they own. And right now, it’s important to look at these two factors above all else.
Top 10 Dow Dividend Stocks
Whether you're looking for a low-risk way to ride the rally or just want a safe place to park your cash, look no further than these blue-chip dividend champs.
U.S. Stocks Are Sinking in International Waters
A stronger dollar is hurting corporate revenue in the second quarter, but as Deere's latest results show, good old-fashioned demand ain't there, either.
6 Pharmaceutical Stocks to Buy Now
The grades of 6 Pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
Israel: Beyond the Risk, Opportunities Beckon
When you think of Israel, you probably think of conflict. But it has a strong economy and growing companies if you're willing to be a bit daring.
How to Pick the Best High-Yield Stocks in Big Pharma
Big Pharma is a great place to find yield, and health care is a sure-fire long-term bet. But rather than shake a stick at this sector, go ahead ... be picky.
Pharma’s Q2 Earnings Lesson: The Big Picture Looks Good
The promising signs coming out of pharma this quarter doesn't mean you can just pick a stock out of a hat -- but it does mean a few are worth picking.
Pfizer Tops Q2 Earnings Estimates
Pfizer posted second-quarter earnings that topped Wall Street estimates even as revenue declined compared to last year.
This New ETF Revolves Around Rotation
The lone new ETF last week, U.S. Equity Rotation Strategy, will shift its holdings among sectors according to the fund managers' view of the markets.
Should I Buy Merck? 3 Pros, 3 Cons
Pharma is a tough game, but thanks to its simultaneous continued R&D spending and cost-cutting, Merck has what it takes to win. Or does it?
6 Pharmaceutical Stocks to Buy Now
The grades of six Pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
For Older Investors, Dividends Trump Bonds
It may not be a surprise that the older demographic tends to be drawn towards dividend stocks, but some other details about dividend investors may surprise you.
Top 10 Dow Dividend Stocks
Looking for the biggest brands with the biggest yields? These 10 blue-chips throw off the best dividends across the entire Dow Jones.
Divided, This Rally Cannot Stand!
The fact that Thursday's rally was restricted to just several sectors following a breakout means a slight correction could be due. Watch for new entry points.
Chasing Yield: Love Dividends, But Diversify
Dividends are popular picks these days, but investors need to be careful. Don't pull all your eggs into one basket just because you see a high yield.
